The influence of blinding and un-blinding on statin related adverse events (AEs): new evidence from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
28 August 2016 (14:00 - 14:15)
Organised by:
Slides
About the speaker
Queen Mary University of London, London (United Kingdom of Great Britain & Northern Ireland)
5 More presentations in this session
Doctor A. Vallejo-Vaz (Seville, ES)
Professor A. Lincoff (Cleveland, US)
Professor A. Eisen (Petah Tikva, IL)
Professor P. Neuzil (Prague, CZ)
Professor E. Standl (Munich, DE)
Access the full session
The Event
ESC Congress 2016
28 August 2016
14:00 CET
You may be interested in
Congress Presentation
Webinar
15 November 2021
Congress Presentation
Congress Presentation
29 August 2022
